08:41 Thursday June 29th 2006
Irish pharmaceutical company Elan is receiving the go-ahead to put its Multiple Sclerosis drug Tysabri back on the market.

The European Commission gave the company permission to release the drug following a recommendation from the European Medicines Agency.

The breakthrough medicine was taken off the market last year following the deaths of two patients, involved in trials of the drug, from a rare brain condition.

US officials cleared Tysabri for use in America earlier this month.

http://www.unison.ie/breakingnews/index.php3?ca=35&si=94106&printer=1